Convert Pfizer Tokenized Stock (Reality) RPFE to Resupply USD REUSD

Pfizer engages in the research, development, clinical testing, and manufacturing of biopharmaceutical products. The company's pipeline focuses on medical areas such as oncology, internal medicine, rare diseases, and vaccines. The business covers laboratory screening, synthesis, and regulatory agency submissions for large and small molecule compounds. After approval, the related medications and preventive preparations are primarily supplied to various hospitals, clinics, and government health management departments through commercial channels.

A decentralized stablecoin backed by Collateralized Debt Positions (CDP), leveraging the liquidity and stability of lending markets. The Resupply stablecoin is backed by other stablecoins that are earning interest on other lending markets. Designed to maximize yield returns by having the borrow rate always be half the lending rate being earned, half the risk-free rate, or two percent, whichever is greater. Emissions are designed for long-term sustainability by directing at three groups: the insurance pool, voting incentives, and directly at borrowers. The revenue that borrowers generate will directly correlate with the emissions directed towards them. The more revenue a borrower generates for Resupply, the greater the share of emissions it will receive. Targeted platforms for launch are Curve Lend and Fraxlend.